The latest advancement in Monarch navigation technology features AI-powered algorithms and a verified OEC open interface with GE HealthCare’s OEC 3D mobile CBCT imaging system. Johnson & Johnson MedTech submitted this technology to the FDA for 510(k) clearance last fall.

Monarch, the first robotic-assisted bronchoscopy system to market, offers minimally invasive access to and visualization of airways. It helps clinicians biopsy suspicious lung nodules. The platform helps deliver early, definitive diagnoses in lung cancer cases to get patients on the treatment pathway faster.

The Monarch Quest platform builds on the system’s stable reach and precision with a unique scope-in-sheath design and continuous vision, according to J&J MedTech. This software also integrates enhanced navigation with intraprocedural 3D imaging data, potentially improving accuracy in targeting lung nodules.